Total Voting Rights

RNS Number : 3841E
Alliance Pharma PLC
08 February 2018
 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Total Voting Rights

 

Alliance Pharma plc (AIM: APH), the specialty pharmaceutical company, makes the following notification in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1.

As at 31 January 2018 the Company's issued share capital consists of 475,008,988 Ordinary Shares of 1p each.

The total number of voting rights in the Company is 475,008,988 and this figure may be used by shareholders as the denominator for the calculations by which they should determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive Officer

Peter Butterfield, Deputy Chief Executive Officer

Andrew Franklin, Chief Financial Officer


www.alliancepharma.co.uk


 

Buchanan

 

+ 44 (0) 20 7466 5000

Mark Court / Sophie Wills / Gemma Mostyn-Owen




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Freddie Barnfield


Corporate Broking: James Black / Toby Adcock




Investec Bank plc

+44 (0) 20 7597 5970

Corporate Finance: Daniel Adams / Ed Thomas

Corporate Broking: Patrick Robb / Rob Baker

 


 

Notes to editors:

 

About Alliance Pharma

 

Alliance, founded in 1998, is an international speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has sales in more than 100 countries worldwide via direct sales, joint ventures and a network of distributors.  Alliance has a strong track record of acquiring the rights to established niche products and it currently owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. The Company continues to explore opportunities to expand its product portfolio.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUGUACPUPRGMR
UK 100

Latest directors dealings